Wexford Capital LP Wave Life Sciences Ltd. Transaction History

Wexford Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$7.99 - $37.6 $617,147 - $2.9 Million	-77,240 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.93 - $42.84 $458,600 - $856,800	20,000 Added 34.94%	77,240 $2.02 Million
Q1 2019 May 15, 2019	BUY	$32.69 - $47.91 $1.54 Million - $2.25 Million	47,000 Added 458.98%	57,240 $2.22 Million
Q4 2018 Feb 14, 2019	BUY	$37.1 - $50.11 $379,904 - $513,126	10,240 New	10,240 $430,000
Q2 2018 Aug 13, 2018	SELL	$33.85 - $50.65 $677,000 - $1.01 Million	-20,000 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$21.8 - $39.35 $109,000 - $196,750	-5,000 Reduced 20.0%	20,000 $702,000
Q3 2017 Nov 13, 2017	BUY	$16.4 - $25.05 $409,999 - $626,250	25,000	25,000 $544,000

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.24B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.